Persistent elevated serum parathyroid hormone levels with normocalcaemia after parathyroidectomy: Secondary hyperparathyroidism or pseudo- hyperparathyroidism?

Plain-language guide to PMID 39566577 (2025): observational study study of Parathyroid Hormone (PTH 1-84) in 186 patients, hyperparathyroidism.

Key Facts

PMID: 39566577
Journal: Cirugia espanola
Year: 2025
Study type: Observational Study
Authors: Benet-Muñoz O et al. (6 authors)
DOI: 10.1016/j.cireng.2024.10.006

What This Study Did, in Plain Language

What Was Tested

The paper reports a study of Parathyroid Hormone (PTH 1-84) in the context of hyperparathyroidism, published as a observational study.

This study aimed to determine the time to normalisation of postoperative parathyroid hormone levels after successful parathyroid surgery and to analyse the pathophysiology of postoperative normocalcaemic hyperparathyroidism.

A univariate analysis was performed to investigate the factors related to the time to normalisation of parathyroid hormone levels.

Who Took Part

According to the abstract, 186 patients were involved.

By PubMed's age tags, the people studied were adults, middle-aged adults and older adults, both men and women.

An observational retrospective study was conducted on a cohort of 186 patients who had undergone parathyroidectomy for primary hyperparathyroidism over a 5-year period.

How the Study Was Run

The timeline in the abstract includes 5 years.

The time to normalisation of the postoperative parathyroid hormone levels was recorded as the output variable.

What Was Measured

Topics PubMed links to this paper include Parathyroidectomy, Parathyroid Hormone, Hyperparathyroidism, Secondary, Calcium and Postoperative Complications.

Author keywords: Deficiencia de vitamina D, Hiperparatiroidismo normocalcémico postoperatorio, Hiperparatiroidismo primario, Postoperative normocalcaemic hyperparathyroidism, Primary hyperparathyroidism and Pseudo-hyperparathyroidism.

What This Means in Plain Language

This is a observational study of Parathyroid Hormone (PTH 1-84) in 186 patients in people with hyperparathyroidism over 5 years.

Its findings take up roughly 8 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2025 (Cirugia espanola), a journal based in Spain.

More context: the Parathyroid Hormone (PTH 1-84) compound page, Hyperparathyroidism research.

Our Notes on the Compound

Parathyroid Hormone (PTH 1-84): The 84-amino-acid hormone that raises blood calcium; full-length PTH (Natpara) has been used in hypoparathyroidism. Teriparatide is its 1-34 fragment.

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.